Brian Peters

Peters is the CEO of a state-level hospital trade association who now sits on the board of the national hospital trade association. This is not unusual within AHA's governance design — state association executives routinely cycle through AHA leadership — but it reveals how the AHA board is structurally captured by insiders. The people setting AHA's national policy agenda are the same people running state-level lobbying operations that benefit from that agenda. There is no independent check; the regulated industry governs both levels of the advocacy apparatus.

Peters simultaneously represents Michigan hospitals (which bill Blue Cross) and sits on the BCBSM Board of Directors and Executive Committee (which pays those bills). This is a textbook dual-loyalty conflict:

On the MHA side, his job is to maximize hospital reimbursement from insurers including BCBSM.

On the BCBSM side, his fiduciary duty is to the insurer and its members/policyholders.

On the AHA side, he shapes national positions on insurer-provider relations.

BCBSM is Michigan's dominant insurer. Peters' presence on both sides of the negotiating table raises questions about whether rate negotiations are truly adversarial or whether they reflect a managed accommodation between entities that share board-level relationships.

Peters' vigorous defense of Certificate of Need laws serves his members' financial interests by blocking competitive entry. While MHA frames CON as protecting "access and quality," health economists widely regard CON as an anti-competitive barrier that raises prices and protects incumbent hospitals. Peters carries this protectionist posture into AHA Board deliberations, where national policy on competition and consolidation is shaped.

When confronted with evidence that hospital consolidation raises costs, Peters publicly disputed the characterization of hospitals as "profiteers" and argued that mergers are necessary for hospitals to bear fixed costs. He cited electronic medical records, liability insurance, and physician subsidization as justifications. This framing deflects from the documented price effects of consolidation and aligns with the interests of Michigan's largest systems — particularly Corewell Health — which benefit from reduced competition.

Tina Freese Decker (Corewell Health CEO) is 2025 AHA Chair. Peters sits on the AHA Board. Corewell is MHA's dominant member system. MHA's podcast and communications amplify Corewell's messaging. This creates a closed loop where:

The state association (MHA/Peters) advocates for policies that benefit the dominant system (Corewell/Freese Decker).

The dominant system's CEO chairs the national association (AHA).

The state association CEO sits on the national board.

All three entities share aligned interests in CON protection, consolidation defense, and Medicaid revenue preservation.

Peters controlled HEALTHPAC disbursements (as Treasurer) and separately served as a fundraising host for state and congressional candidates. This dual role — institutional PAC gatekeeper and personal fundraising bundler — gives him unusual leverage over Michigan politicians who depend on hospital industry money. Legislators who might otherwise scrutinize hospital pricing, CON, or consolidation have a financial reason to defer to MHA's positions.

Peters has spent his entire career at MHA — 34 years, rising from staff to CEO with an indefinite appointment. This is not a red flag per se, but it indicates deep institutional capture: Peters' professional identity, compensation, relationships, and worldview are entirely products of the hospital trade association ecosystem. There is no outside perspective, no career experience in patient advocacy, insurance, regulation, or direct care delivery. He is a career lobbyist who now sits on the board of the entity he lobbies for at the national level.

Peters was appointed by Gov. Whitmer to the Michigan Economic Recovery Council (COVID-era) and the 2020 Census Complete Count Committee. While these are advisory roles, they demonstrate a direct channel to the Governor's office that complements MHA's legislative lobbying. During COVID, hospital associations nationwide leveraged emergency advisory roles to shape funding distribution, regulatory waivers, and reopening policies in ways that benefited hospital systems.

The MHA Service Corporation is a for-profit entity that sells services to the healthcare industry. Its financials, client list, and relationship to MHA's advocacy agenda are not transparent. Trade associations commonly use service corporations to generate revenue that subsidizes lobbying and to create commercial relationships with the same entities the association advocates for — a potential conflict of interest that warrants scrutiny.